The Cleveland Clinic Center for Brain Health in Las Vegas is participating in a new trial aiming to delay the onset of Alzheimer’s symptoms. The trial is happening for the next four years in Las Vegas. The Cleveland Clinic, a large health organization in Las Vegas, is currently looking for volunteers to participate in the trial.
It is estimated that about 49,000 Nevadans live with Alzheimer’s disease. And just under that number of people are caretakers for these patients. The Cleveland Clinic has been testing a drug called Lecanemeb on patients with Alzheimer’s and have had positive results. The drug has been effective in treating those who currently live with the symptoms of Alzheimer’s.
Now The Cleveland Clinic wants to take it a step further. They want to do a trial testing Lecanemeb on patients who don’t yet show the signs of the disease. They are looking for people over the age of 55 who have a family history of Alzheimer’s. Especially if they have noticed some changes in themselves lately.
What they will do first is a blood test on any potential participant to see if they have a protein called amyloid in their blood. If they do, the next step is to get imaging of the participant’s brain. This will tell whether the amyloid protein is being accumulated in the brain. If it is, the participant will begin the trial.
Lecanemeb has effectively removed the amyloid protein in the brain’s of people already experiencing Alzheimer’s symptoms. Now The Cleveland Clinic wants to see if the same drug can help people before they experience symptoms. In an interview with Fox 5 Vegas, Doctor Charles Bernick with the Cleveland Clinic said, “The idea is if we can get the amyloid out of the brain early before people have symptoms, we can actually impact the disease and possibly prevent or delay the symptoms of Alzheimer’s disease.”
Here are 10 early signs and symptoms of Alzheimer’s, according to the Alzheimer’s Association.